Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Stephen Cohen

Gynecology Syracuse, NY Medical Doctor

NPI 1275535734 CMS profile 284267

739 Irving Ave, Suite 530, Syracuse, NY 13210

Open in the dashboard

General payments

$204,390

258 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$16,320 paid to institutions, not to them · program year 2019

Through program year 2022, Stephen Cohen of Syracuse, NY is reported in the CMS Open Payments database as having received $204,390 across 258 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $16,320 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $13,588 13
2021 General $28,128 29
2020 General $22,144 24
2019 General $140,530 192

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Cohen
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Stephen Cohen were reported at $0. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Stephen Cohen Gynecology median Middle half National median
2019 $140,530 $199 $66–$472 $163
2020 $22,144 $114 $42–$287 $114
2021 $28,128 $141 $42–$430 $132
2022 $13,588 $173 $52–$532 $149
2023 $0 $170 $57–$501 $160
2024 $0 $157 $50–$424 $164
2025 $0 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. AbbVie, Inc. $202,981 221 payments
  2. Amgen Inc. $801 10 payments
  3. Radius Health, Inc. $217 4 payments
  4. TherapeuticsMD, Inc. $79 6 payments
  5. Teleflex LLC $75 1 payment
  6. Allergan Inc. $47 3 payments
  7. Novo Nordisk Inc $40 3 payments
  8. Vertical Pharmaceuticals, LLC $35 2 payments
  9. Pfizer Inc. $24 2 payments
  10. Bayer HealthCare Pharmaceuticals Inc. $24 1 payment
  11. Other $67 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $155,800 61 payments
  2. Travel and Lodging $31,595 78 payments
  3. Consulting Fee $11,250 4 payments
  4. Food and Beverage $5,738 114 payments
  5. Education $7 1 payment
Products named General payments · program years 2019–2022
  1. Orilissa Endocrinology $139,104 154 payments
  2. ORIAHNN $48,051 48 payments
  3. ORILISSA Womens Health $21,960 22 payments
  4. Prolia $432 7 payments
  5. EVENITY $322 6 payments
  6. Tymlos $217 4 payments
  7. IMVEXXY $79 6 payments
  8. Percutaneous Solutions: PERCUVANCE & MiniLap brands $75 1 payment
  9. LO LOESTRIN FE $47 3 payments
  10. Saxenda $40 3 payments
  11. Other $222 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

258 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record